Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2021-09-01 00:00:00 ET · period of report 2021-08-30 · accession 0001209191-21-054302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-01 | 2021-08-30 | TVRD | Menzaghi Frederique Ph.D. | Chief Scientific Off, SVP-R, D | S - Sale | $14.20 | -3,847 | 141.1K | -3% | -$54.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | S | D | 3,847 | $14.20 | 141,072 | D | — | — |